Loss of GATA3 in bladder cancer promotes cell migration and invasion

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69 - 90; http://dx.doi.org/10.3322/caac.20107; PMID: 21296855
   PubMed Web of Science ®Google Scholar
• Miyamoto H, Yang Z, Chen Y-T, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang Y-J, Hu Y-C, Tsai M-Y, et al. Promotion of bladder cancer development and progression by androgen receptor signals. J Natl Cancer Inst 2007; 99:558 - 68; http://dx.doi.org/10.1093/jnci/djk113; PMID: 17406000
   PubMed Web of Science ®Google Scholar
• Ho IC, Vorhees P, Marin N, Oakley BK, Tsai SF, Orkin SH, Leiden JM. Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J 1991; 10:1187 - 92; PMID: 1827068
   PubMed Web of Science ®Google Scholar
• Ko LJ, Yamamoto M, Leonard MW, George KM, Ting P, Engel JD. Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol Cell Biol 1991; 11:2778 - 84; PMID: 2017177
   PubMed Web of Science ®Google Scholar
• Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai S-Y, Ho I-C, Werb Z. GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. Cancer Cell 2008; 13:141 - 52; http://dx.doi.org/10.1016/j.ccr.2008.01.011; PMID: 18242514
   PubMed Web of Science ®Google Scholar
• Asselin-Labat ML, Sutherland KD, Vaillant F, Gyorki DE, Wu D, Holroyd S, Breslin K, Ward T, Shi W, Bath ML, et al. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol Cell Biol 2011; 31:4609 - 22; http://dx.doi.org/10.1128/MCB.05766-11; PMID: 21930782
   PubMed Web of Science ®Google Scholar
• Dydensborg AB, Rose AAN, Wilson BJ, Grote D, Paquet M, Giguère V, Siegel PM, Bouchard M. GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis. Oncogene 2009; 28:2634 - 42; http://dx.doi.org/10.1038/onc.2009.126; PMID: 19483726
   PubMed Web of Science ®Google Scholar
• Hoch RV, Thompson DA, Baker RJ, Weigel RJ. GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 1999; 84:122 - 8; http://dx.doi.org/10.1002/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S; PMID: 10096242
   PubMed Web of Science ®Google Scholar
• Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it!. J Cell Physiol 2010; 222:42 - 9; http://dx.doi.org/10.1002/jcp.21943; PMID: 19798694
   PubMed Web of Science ®Google Scholar
• Yoon NK, Maresh EL, Shen D, Elshimali Y, Apple S, Horvath S, Mah V, Bose S, Chia D, Chang HR, et al. Higher levels of GATA3 predict better survival in women with breast cancer. Hum Pathol 2010; 41:1794 - 801; http://dx.doi.org/10.1016/j.humpath.2010.06.010; PMID: 21078439
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, Marinelli RJ, Presti JC Jr., van de Rijn M, Brooks JD. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol 2007; 31:673 - 80; http://dx.doi.org/10.1097/01.pas.0000213438.01278.5f; PMID: 17460449
   PubMed Web of Science ®Google Scholar
• Liu H, Shi J, Wilkerson ML, Lin F. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol 2012; 138:57 - 64; http://dx.doi.org/10.1309/AJCP5UAFMSA9ZQBZ; PMID: 22706858
   PubMed Web of Science ®Google Scholar
• Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol 2012; 36:1472 - 6; http://dx.doi.org/10.1097/PAS.0b013e318260cde7; PMID: 22982890
   PubMed Web of Science ®Google Scholar
• Miyamoto H, Izumi K, Yao JL, Li Y, Yang Q, McMahon LA, Gonzalez-Roibon N, Hicks DG, Tacha D, Netto GJ. GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor. Hum Pathol 2012; 43:2033 - 40; http://dx.doi.org/10.1016/j.humpath.2012.02.011; PMID: 22607700
   PubMed Web of Science ®Google Scholar
• Nguyen AHT, Tremblay M, Haigh K, Koumakpayi IH, Paquet M, Pandolfi PP, Mes-Masson A-M, Saad F, Haigh JJ, Bouchard M. Gata3 antagonizes cancer progression in Pten-deficient prostates. Hum Mol Genet 2013; 22:2400 - 10; http://dx.doi.org/10.1093/hmg/ddt088; PMID: 23428429
   PubMed Web of Science ®Google Scholar
• Cook KD, Miller J. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J Immunol 2010; 185:3209 - 16; http://dx.doi.org/10.4049/jimmunol.0902544; PMID: 20696860
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141:52 - 67; http://dx.doi.org/10.1016/j.cell.2010.03.015; PMID: 20371345
   PubMed Web of Science ®Google Scholar
• Zheng Y, Izumi K, Li Y, Ishiguro H, Miyamoto H. Contrary regulation of bladder cancer cell proliferation and invasion by dexamethasone-mediated glucocorticoid receptor signals. Mol Cancer Ther 2012; 11:2621 - 32; http://dx.doi.org/10.1158/1535-7163.MCT-12-0621; PMID: 23033490
   PubMed Web of Science ®Google Scholar
• McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009; 28:335 - 44; http://dx.doi.org/10.1007/s10555-009-9194-7; PMID: 20012924
   PubMed Web of Science ®Google Scholar
• Asselin-Labat M-L, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2007; 9:201 - 9; http://dx.doi.org/10.1038/ncb1530; PMID: 17187062
   PubMed Web of Science ®Google Scholar
• Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 2006; 127:1041 - 55; http://dx.doi.org/10.1016/j.cell.2006.09.048; PMID: 17129787
   PubMed Web of Science ®Google Scholar
• Yan W, Cao QJ, Arenas RB, Bentley B, Shao R. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem 2010; 285:14042 - 51; http://dx.doi.org/10.1074/jbc.M110.105262; PMID: 20189993
   PubMed Web of Science ®Google Scholar
• Kusy S, Gerby B, Goardon N, Gault N, Ferri F, Gérard D, Armstrong F, Ballerini P, Cayuela JM, Baruchel A, et al. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia. J Exp Med 2010; 207:2141 - 56; http://dx.doi.org/10.1084/jem.20100745; PMID: 20855495
   PubMed Web of Science ®Google Scholar
• Wilson BJ, Giguère V. Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway. Mol Cancer 2008; 7:49; http://dx.doi.org/10.1186/1476-4598-7-49; PMID: 18533032
   PubMed Web of Science ®Google Scholar
• Miyamoto H, Zheng Y, Izumi K. Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma. Curr Cancer Drug Targets 2012; 12:14 - 22; http://dx.doi.org/10.2174/156800912798888965; PMID: 22111835
   PubMed Web of Science ®Google Scholar
• Li Y, Izumi K, Miyamoto H. The role of the androgen receptor in the development and progression of bladder cancer. Jpn J Clin Oncol 2012; 42:569 - 77; http://dx.doi.org/10.1093/jjco/hys072; PMID: 22593639
   PubMed Web of Science ®Google Scholar
• Hsu I, Vitkus S, Da J, Yeh S. Role of oestrogen receptors in bladder cancer development. Nat Rev Urol 2013; 10:317 - 26; http://dx.doi.org/10.1038/nrurol.2013.53; PMID: 23588401
   PubMed Web of Science ®Google Scholar
• Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder. BJU Int 2012; 109:1716 - 26; http://dx.doi.org/10.1111/j.1464-410X.2011.10706.x; PMID: 22221549
   PubMed Web of Science ®Google Scholar
• Li Y, Zheng Y, Izumi K, Ishiguro H, Ye B, Li F, Miyamoto H. Androgen activates β-catenin signaling in bladder cancer cells. Endocr Relat Cancer 2013; 20:293 - 304; http://dx.doi.org/10.1530/ERC-12-0328; PMID: 23447569
   PubMed Web of Science ®Google Scholar
• Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL, Netto GJ, Miyamoto H. Expression of UDP-glucuronosyltransferase 1A in bladder cancer: Association with prognosis and regulation by estrogen. Mol Carcinog 2012; In press http://dx.doi.org/10.1002/mc.21978; PMID: 23143693
   PubMed Web of Science ®Google Scholar
• Zheng Y, Izumi K, Yao JL, Miyamoto H. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells. Endocr Relat Cancer 2011; 18:451 - 64; http://dx.doi.org/10.1530/ERC-11-0010; PMID: 21613411
   PubMed Web of Science ®Google Scholar
• Gulbinas A, Berberat PO, Dambrauskas Z, Giese T, Giese N, Autschbach F, Kleeff J, Meuer S, Büchler MW, Friess H. Aberrant gata-3 expression in human pancreatic cancer. J Histochem Cytochem 2006; 54:161 - 9; http://dx.doi.org/10.1369/jhc.5A6626.2005; PMID: 16087702
   PubMed Web of Science ®Google Scholar
• Engelsen IB, Stefansson IM, Akslen LA, Salvesen HB. GATA3 expression in estrogen receptor α-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival. Am J Obstet Gynecol 2008; 199:543.e1 - 7; http://dx.doi.org/10.1016/j.ajog.2008.04.043; PMID: 18599012
   PubMedGoogle Scholar
• Hoene V, Fischer M, Ivanova A, Wallach T, Berthold F, Dame C. GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes. Br J Cancer 2009; 101:1481 - 9; http://dx.doi.org/10.1038/sj.bjc.6605276; PMID: 19707195
   PubMed Web of Science ®Google Scholar
• Molenaar JJ, Ebus ME, Koster J, Santo E, Geerts D, Versteeg R, Caron HN. Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells. Oncogene 2010; 29:2739 - 45; http://dx.doi.org/10.1038/onc.2010.21; PMID: 20154722
   PubMed Web of Science ®Google Scholar
• Shan L, Li X, Liu L, Ding X, Wang Q, Zheng Y, Duan Y, Xuan C, Wang Y, Yang F, et al. GATA3 cooperates with PARP1 to regulate CCND1 transcription through modulating histone H1 incorporation. Oncogene 2013; In press http://dx.doi.org/10.1038/onc.2013.270; PMID: 23851505
   PubMed Web of Science ®Google Scholar
• Izumi K, Zheng Y, Li Y, Zaengle J, Miyamoto H. Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor. Int J Oncol 2012; 41:1587 - 92; PMID: 22922989
   PubMed Web of Science ®Google Scholar
• Izumi K, Zheng Y, Hsu J-W, Chang C, Miyamoto H. Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis. Mol Carcinog 2013; 52:94 - 102; http://dx.doi.org/10.1002/mc.21833; PMID: 22086872
   PubMed Web of Science ®Google Scholar